Published on: 2026-11-09
Source: Government of the Russian Federation –
An important disclaimer is at the bottom of this article.
Deputy Prime Minister Tatyana Golikova participated in the IV International Forum on Nature-Like Technologies at the National Research Center “Kurchatov Institute.” The forum was opened by the President of the NRC “Kurchatov Institute,” Mikhail Kovalchuk. The forum was also attended by the CEO of the state corporation “Roscosmos,” Dmitry Bakanov, Chairman of the State Duma Committee on Science and Higher Education Sergey Kabyshev, Vice-President of the Russian Academy of Sciences Vladislav Panchenko, Director of the Russian Scientific Center of Surgery named after Academician B.V. Petrovsky Konstantin Kotenko, and others.
Tatiana Golikova noted that nature-like technologies are widely developing in Russia. This process was driven by the new coronavirus infection and the scientific research conducted in the following years. In 2023, the head of state signed a Decree “On the development of nature-like technologies in the Russian Federation,” and the priority development directions were approved by the Government this year. The functions of the leading scientific organization have been assigned to the NRC “Kurchatov Institute.”
“Today, medical science faces the task not just of creating new medical technologies, but of creating technologies that work together with the human body. Nature-inspired solutions in healthcare mean transferring evolutionary natural mechanisms into clinical practice; this is the path to truly personalized, gentle, and preservative medicine. The key value is biocompatibility, working with human nature, not against it. We already have the scientific and material base, strong scientific schools, and operational medical products and technologies. We will continue to develop our own leading advances, in which nature will become our co-author in creating the technologies of the future,” said Tatyana Golikova.
She emphasized that the active development of nature-mimicking technologies in healthcare began within the framework of the federal scientific and technical program for the development of genetic technologies. In genetics, this allowed the development and practical implementation of 79 different test systems and the first gene therapy medicinal product for the treatment of Behçet’s disease.
Also, with the help of genetics, individualized biomimetic drugs with specified properties have been developed in Russia. Starting this year, three such drugs for the treatment of leukemias, lymphomas, and cancers of the digestive and respiratory organs are being used within the framework of compulsory medical insurance. Next year, two more drugs that train the immune system to recognize tumor cells will become available under the compulsory medical insurance system—for the treatment of skin melanoma and gastrointestinal tumors. A vaccine for birch pollen allergy has been registered and has begun to be used. These are unique Russian products with no global analogues.
The Deputy Prime Minister noted that nature-inspired technologies are in high demand in regenerative biomedicine. In 2024, the first tissue engineering product for the treatment of knee joint osteoarthritis was introduced into practice. The patient’s own cells are used to restore cartilage tissue of large joints. Starting from 2027, biomedical cellular products will begin to be used for intestinal diseases, wound, and burn treatment. The development of this direction is taking place within the framework of the national project “New Health Preservation Technologies.”
Tatiana Golikova emphasized that a new direction in the development of medical science worldwide is the creation and use of biodegradable implants and vascular prostheses. By the end of the current year, the use of the first Russian biodegradable screws for bone fusion in fractures will begin, which will not need to be removed through repeated surgeries. Starting in 2027, the first biodegradable prostheses for large vessels will be introduced in Russia, marking a breakthrough in vascular surgery. The leader of this technology in our country is the RNTSH named after Academician B.V. Petrovsky of the Ministry of Education and Science of Russia. After implantation, the material of biodegradable vascular prostheses gradually dissolves, and a healthy, elastic vessel forms in its place.
Also, the Deputy Prime Minister drew attention to cognitive biomimetic technologies, which are used for modeling cognitive architectures of the brain for the purpose of diagnosing neurodegenerative diseases and their correction. In Russia, from 2023 to 2026, 28 domestically produced medical devices based on cognitive biomimetic technologies have been registered.
The most important example of the application of nature-like technologies in healthcare is nuclear medicine. Radiopharmaceutical drugs accumulate in tissues and organs due to the similarity of their chemical properties to natural compounds. They are used in cardiology, neurology, oncology, endocrinology for diagnosis and treatment. Charged particles behave in the body similarly to natural trace elements, participating in the physiological processes of the body. This allows the body’s function to be finely tuned rather than disrupted, without damaging healthy organs and tissues. In Russia, 64 radiopharmaceutical drugs are registered, 60 of which are produced in our country.
Speaking about the medicine of healthy longevity, Tatyana Golikova noted that this field is based solely on nature-like technologies – from determining biological age using calculators and medical devices to creating geroprotectors with specific properties. Active development of this direction will continue in the coming years.
Please note; This information is raw content obtained directly from the information source. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.